Myelodysplastic Syndromes Clinical Trials in St Louis, Missouri
9 recruitingSt Louis, Missouri
Showing 1–9 of 9 trials
Recruiting
Phase 1Phase 2
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Myelodysplastic SyndromesMyelofibrosisAnemia+4 more
Disc Medicine, Inc150 enrolled24 locationsNCT05320198
Recruiting
Phase 2
Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)
Myelodysplastic SyndromesClonal Cytopenia of Undetermined Significance
Washington University School of Medicine16 enrolled1 locationNCT05483010
Recruiting
Phase 1Phase 2
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
Myelodysplastic Syndromes
Washington University School of Medicine209 enrolled1 locationNCT04742634
Recruiting
Phase 1
A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies
Chronic Myeloid LeukemiaMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more
MacroGenics130 enrolled7 locationsNCT05362773
Recruiting
Not Applicable
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
Myelodysplastic SyndromesWhole Genome Sequencing
Washington University School of Medicine60 enrolled1 locationNCT05434598
Recruiting
Phase 1Phase 2
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)
Low Risk Myelodysplastic Syndromes
Rigel Pharmaceuticals86 enrolled15 locationsNCT05308264
Recruiting
Not Applicable
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS
Acute Myeloid LeukemiaMyelodysplastic SyndromesWhole Genome Sequencing
Washington University School of Medicine325 enrolled1 locationNCT04986657
Recruiting
Phase 2
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Sawa Ito, MD45 enrolled3 locationsNCT06529731
Recruiting
Phase 1
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
Myelodysplastic SyndromesRelapsed or Refractory Acute Myeloid Leukemia (AML)Untreated AML+1 more
Institut de Recherches Internationales Servier291 enrolled30 locationsNCT02074839